MCID: GLL022

Guillain-barre Syndrome malady

Summaries for Guillain-barre Syndrome

Sources:
6Disease Ontology, 30NIH Rare Diseases, 23MedlinePlus, 2CDC, 31NINDS, 17Genetics Home Reference, 44Wikipedia, 22MalaCards
See all sources

Export this MalaCard
MedlinePlus: Guillain-barre syndrome is a rare disorder that causes your immune system to attack your peripheral nervous system (pns). the pns nerves connect your brain and spinal cord with the rest of your body. damage to these nerves makes it hard for them to transmit signals. as a result, your muscles have trouble responding to your brain. no one knows what causes the syndrome. sometimes it is triggered by an infection, surgery or a vaccination. the first symptom is usually weakness or a tingling feeling in your legs. the feeling can spread to your upper body. in severe cases, you become almost paralyzed. this is life-threatening. you might need a respirator to breathe. symptoms usually worsen over a period of weeks, then stabilize. most people recover. recovery can take a few weeks to a few years. treatment options during the symptom period include medicines or a procedure called plasma exchange. nih: national institute of neurological disorders and stroke23

MalaCards: Guillain-barre Syndrome, also known as acute inflammatory polyneuropathy, is related to chronic inflammatory demyelinating polyradiculoneuropathy and miller fisher syndrome. An important gene associated with Guillain-barre Syndrome is PMP2 (peripheral myelin protein 2), and among its related pathways are Cell adhesion molecules (CAMs) and Immune response_NFAT in immune response. The drug globulin,immune (iv) and the compounds ivig and endotoxin have been mentioned in the context of this disorder. Affiliated tissues include brain, spinal cord and t cells, and related mouse phenotypes are renal/urinary system and hematopoietic system.

Disease Ontology: An autoimmune disease of peripheral nervous system that causes body's immune system to attack part of the peripheral nervous system.6

NIH Rare Diseases: Guillain-Barre syndrome is a rare disorder in which the body's immune system attacks part of the peripheral nervous system. Symptoms of this disorder include muscle weakness, numbness, and tingling sensations, which can increase in intensity until the muscles cannot be used at all. Usually Guillain-Barre syndrome occurs a few days or weeks after a person has had symptoms of a viral infection. Occasionally, surgery or vaccinations will trigger the syndrome. It remains unclear why only some people develop Guillain-Barre syndrome. Most patients recover completely, although some continue to have some degree of weakness.30

CDC: Group B Streptococcus (group B strep, GBS) is a type of bacteria that causes illness in people of all ages. It is the most common cause of some life-threatening infections in newborns, but it can be prevented.2

NINDS: Miller Fisher syndrome is a rare, acquired nerve disease that is considered to be a variant of Guillain-Barr31

Genetics Home Reference: Guillain-Barré syndrome is an autoimmune disorder that affects the nerves. Autoimmune disorders occur when the immune system malfunctions and attacks the body's own tissues and organs. In Guillain-Barré syndrome, the immune response damages peripheral nerves, which are the nerves that connect the central nervous system (the brain and spinal cord) to the limbs and organs. Specifically, the immune response affects a particular part of peripheral nerves called axons, which are the extensions of nerve cells (neurons) that transmit nerve impulses. Guillain-Barré syndrome can affect the neurons that control muscle movement (motor neurons); the neurons that transmit sensory signals such as pain, temperature, and touch (sensory neurons); or both. As a result, affected individuals can experience muscle weakness or lose the ability to feel certain sensations.17

Wikipedia: Guillain–Barré syndrome (GBS) (French pronunciation:44 more...

Aliases & Descriptions for Guillain-barre Syndrome

Sources:
2CDC, 43UMLS, 6Disease Ontology, 30NIH Rare Diseases, 8DISEASES, 32Novoseek , 23MedlinePlus, 17Genetics Home Reference, 31NINDS, 40SNOMED-CT, 24MeSH, 33OMIM, 19ICD9CM, 27NCIt
See all sources

Aliases & Descriptions:

guillain-barre syndrome 6 30 8 32 23 43
acute inflammatory polyneuropathy 30 17
guillain-barré syndrome 17 31
fisher syndrome 17 31
gbs 30 17
acute inflammatory demyelinating polyradiculoneuropathy 30
acute inflammatory demyelinating polyneuropathy 30
acute infective polyneuritis nos (disorder) 6
post-infectious polyneuritis (disorder) 6
acute infective polyneuritis (disorder) 6
acute autoimmune peripheral neuropathy 30
landry-guillain-barre-strohl syndrome 30
acute immune-mediated polyneuropathy 30
acute postinfectious polyneuropathy 6
guillain-barre syndrome (disorder) 6
guillain-barre syndrome, familial 43
infectious neuronitis (disorder) 6
landry-guillain-barre syndrome 17
acute infectious polyneuritis 17
acute inflammatory neuropathy 30
landry's ascending paralysis 30
acute infective polyneuritis 6
postinfectious polyneuritis 6
post-infective polyneuritis 30
acute inf. polyneuritis 6
miller fisher syndrome 43
polyneuritis 43

Related Diseases for Guillain-barre Syndrome

Sources:
13GeneCards, 14GeneDecks
See all sources

Diseases related to guillain-barre syndrome by text searches and GeneDecks gene sharing:

(show top 50)    (show all 669)
idRelated DiseaseScoreTop Affiliating Genes
1chronic inflammatory demyelinating polyradiculoneuropathy33.6MPZ, CCR5, PMP22
2miller fisher syndrome32.9TNF, SRF
3hepatitis32.3FAS, HLA-DRB1, TNFRSF1A, CR1
4demyelinating polyneuropathy32.0CD40LG, CD1E, CD1D, IL10, TUBB, TNF
5polyradiculoneuropathy31.7MPZ, CD40LG, MBP, CCR5, CCL21, CCL19
6chronic inflammatory demyelinating polyneuropathy30.5CD1D, TUBB, TNF
7paralysis30.3MPZ, MOG, IL10, MBP, HCRT, PMP2
8hepatitis c27.9CD40LG, IL10, FAS, CCR5, IFNG, HP
9polyneuropathy27.8MPZ, CD79A, CD40LG, CD1D, MMP9, IL10
10nonalcoholic steatohepatitis26.9FAS, TNF, TNFRSF1A, TNFRSF1B
11pharyngitis26.7CD79A, CD1A, MMP9, HP, HLA-DRB1, TNF
12herpes simplex26.1CD79A, CD40LG, CD1D, IL10, APOE, FAS
13hepatitis b25.9IL10, MBL2, CCR5, IFNG, HLA-DQB1, HLA-DRB1
14breast cancer25.2MMP9, IL10, IFNG, TNF, CRYAB
15kaposi's sarcoma23.9MMP9, FCGR3A, IL10, IFNG, HLA-DQB1, HLA-DRB1
16immunodeficiency23.6MPZ, MOG, CD79A, CD40LG, CD1A, CD1D
17breast carcinoma22.9CD40LG, CD1A, MMP9, APOE, FAS, MBL2
18cervicitis21.0MPZ, CD79A, CD1A, MMP9, FCGR2A, FCGR3A
19sarcoma19.9YWHAQ, CD40LG, CD1A, MMP9, FCGR3A, IL10
20glioblastoma19.5MMP9, GSC, IL10, APOE, FAS, MBP
21gastric cancer18.8CD40LG, MMP9, FCGR2A, FCGR3A, IL10, APOE
22diabetes mellitus18.6CD79A, CD40LG, CD1D, MMP9, IL10, APOE
23hepatocellular carcinoma18.5CD1D, MMP9, IL10, APOE, FAS, MBL2
24carcinoma18.1CD79A, CD40LG, CD1A, CD1D, MMP9, FCGR3A
25leukemia15.6CD79A, CD40LG, CD1E, CD1A, CD1D, CD1C
26roussy-levy syndrome13.8MPZ, PMP22
27motor peripheral neuropathy13.8MPZ, PMP22
28charcot-marie-tooth disease type 1b13.8MPZ, PMP22
29hereditary neuropathies13.8MPZ, PLP1, PMP22
30acid sphingomyelinase deficiency13.8MPZ, MBP, PLP1
31pelizaeus-merzbacher disease13.7MPZ, MBP, PLP1, PMP22
32niemann–pick disease13.7MPZ, MBP, PLP1, HCRT
33axonal neuropathy13.7MPZ, TUBB, PLP1, PMP22
34charcot-marie-tooth disease13.7MPZ, PMP22
35charcot-marie-tooth neuropathy type 1a13.6MPZ, PMP22
36mycobacterium malmoense13.6CD1E, CD1A, CD1D, CD1C
37charcot-marie-tooth neuropathy type 4e13.6MPZ, PMP22
38secondary syphilis13.6CD79A, CD40LG, CCR5
39congenital toxoplasmosis13.6CD79A, CD40LG
40autoimmune disease of the nervous system13.6CD79A, MBP
41aids, resistance to13.6CCR5, CXCL12
42cd40 ligand deficiency13.6CD79A, CD40LG, SRF
43primary immunodeficiency disease13.6CD40LG, FCGR3A, FCGR3B
44acute disseminated encephalomyelitis13.5MBP, HCRT
45kleine-levin syndrome13.5HLA-DRB1, HCRT
46neurilemmoma13.5MPZ, MBP, CRYAB, GFAP, PMP22
47chiari malformation type 213.4CD79A, MBP, TH
48chiari malformation13.4CD79A, MBP, TH
49foot drop13.4MPZ, TNF, PMP22
50celiac disease13.4HLA-DQA1, HLA-DQB1

Graphical network of the top 20 diseases related to guillain-barre syndrome:



Graphical network of diseases related to guillain-barre syndrome

Clinical Features for Guillain-barre Syndrome

Drugs & Therapeutics for Guillain-barre Syndrome

Sources:
4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT
See all sources

Approved drugs:

Search CenterWatch for guillain-barre syndrome

Drug clinical trials:

Search ClinicalTrials for guillain-barre syndrome

Search NIH Clinical Center for guillain-barre syndrome

Search CenterWatch for guillain-barre syndrome

Inferred drug relations via UMLS/NDF-RT:

43 28 globulin,immune (iv)

Genetic Tests for Guillain-barre Syndrome

Anatomical Context for Guillain-barre Syndrome

Sources:
22MalaCards
See all sources

MalaCards organs/tissues related to guillain-barre syndrome:

22
Brain, Spinal cord, T cells, B cells

Phenotypes for genes affiliated with Guillain-barre Syndrome

Sources:
25MGI
See all sources

MGI Mouse Phenotypes related to guillain-barre syndrome:

25 (show all 21)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1renal/urinary system phenotypeMP:00053679.9TNFRSF1B, APOE, CD1D
2hematopoietic system phenotypeMP:00053979.9HLA-DQB1, HLA-DQA1, IGKC, CCL19, CD1D
3liver/biliary system phenotypeMP:00053709.8TH, IFNG, CCR5, CD1D
4respiratory system phenotypeMP:00053889.6TH, HCRT, SRF, APOE, GSC, CD1D
5endocrine/exocrine gland phenotypeMP:00053799.6CD40LG, GSC, IFNG, HMGA2
6no phenotypic analysisMP:00030129.3SRF, IGKC, CCR5, FCGR3A, CD79A
7skeleton phenotypeMP:00053909.2CRYAB, SRF, TNFRSF1B, TNFRSF1A, FAS, GSC
8integument phenotypeMP:00107718.8TH, TNFRSF1B, TNFRSF1A, HMGA2, IFNG, FAS
9nervous system phenotypeMP:00036318.6TNFRSF1B, PLP1, HCRT, TH, CXCL12, PMP22
10digestive/alimentary phenotypeMP:00053818.1GFAP, NOS2, CRYAB, IFNG, CCR5, APOE
11growth/size phenotypeMP:00053788.0PLP1, ACP1, HCRT, GFAP, TH, PMP22
12immune system phenotypeMP:00053877.2MPZ, GFAP, ACP1, PLP1, CRYAB, SRF
13mortality/agingMP:00107686.9TNFRSF1A, SRF, CRYAB, PLP1, NOS2, GFAP
14reproductive system phenotypeMP:00053896.9PMP22, NOS2, PLP1, TNFRSF1A, TNF, HMGA2
15tumorigenesisMP:00020066.5NOS2, TNFRSF1B, TNFRSF1A, TNF, HP, IFNG
16homeostasis/metabolism phenotypeMP:00053766.3HMGA2, HLA-DQB1, TNFRSF1A, TNFRSF1B, SRF, PLP1
17muscle phenotypeMP:00053696.1TNFRSF1B, SRF, CRYAB, NOS2, HCRT, GFAP
18vision/eye phenotypeMP:00053915.7TNFRSF1A, TNFRSF1B, CRYAB, PLP1, NOS2, GFAP
19cardiovascular system phenotypeMP:00053854.8TNF, TNFRSF1A, TNFRSF1B, SRF, NOS2, HCRT
20behavior/neurological phenotypeMP:00053864.7TNF, TNFRSF1A, TNFRSF1B, SRF, CRYAB, PLP1
21cellular phenotypeMP:00053844.1TNFRSF1B, TNFRSF1A, TNF, HLA-DQB1, HP, SRF

Publications for genes affiliated with Guillain-barre Syndrome

Sources:
35PubMed
See all sources

Articles related to guillain-barre syndrome:

(show all 32)
idTitleAuthorsYearAffiliating Genes
1Autoantibody-mediated dysfunction of sympathetic neur ons in guillain-barre syndrome. (20142528)Lehmann H.C.... Kieseier B.C.2010TH
2Glial fibrillary acidic protein: a marker of axonal Guillain-Barre syndrome and outcome. (18508349)Notturno F.... Uncini A.2008GFAP
3Immune responses to myelin proteins in Guillain-Barre syndrome. (17717020)Makowska A.... Hughes R.2008IL10, MPZ
4The 'Child in the Barrel syndrome'--severe pharyngeal-cervical-brachial variant of Guillain-Barre Syndrome in a toddler. (19569002)Rousseff R.T.... Neubauer D.2008ACP1, HP
5Intrathecal anti-alphaB-crystallin IgG antibody responses: potential inflammatory markers in Guillain-Barre syndrome. (18712293)Wanschitz J.... Berger T.2008CRYAB
6Susceptibility to Guillain-Barre syndrome is not associated with CD1A and CD1E gene polymorphisms. (18838176)Kuijf M.L.... Jacobs B.C.2008CD1A, CD1E
7Association of tumor necrosis factor polymorphisms with Guillain-Barre syndrome. (17483581)Zhang J.... Guo L.2007TNF
8Genetic polymorphisms of macrophage-mediators in Guillain-Barre syndrome. (17761309)Geleijns K.... Jacobs B.C.2007MMP9, TNF, NOS2
9Mannose-binding lectin contributes to the severity of Guillain-Barre syndrome. (16951387)Geleijns K.... Jacobs B.C.2006MBL2
10Studies of HLA associations in male and female patients with Guillain-Barre syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). (16935351)McCombe P.A.... Greer J.M.2006HLA-DRB1
11Susceptibility to Guillain-Barre syndrome is associated to polymorphisms of CD1 genes. (16820217)Caporale C.M.... Uncini A.2006CD1D, CD1A, CD1E
12Detection of CSF 14-3-3 protein in Guillain-Barre syndrome. (17190946)Bersano A.... Nobile-Orazio E.2006YWHAQ
13HLA class II alleles are not a general susceptibility factor in Guillain-Barre syndrome. (15642902)Geleijns K.... van Doorn P.A.2005HLA-DQA1, HLA-DRB1
14Severity of Guillain-Barre syndrome is associated with Fc gamma Receptor III polymorphisms. (15833371)van Sorge N.M.... van den Berg L.H.2005FCGR3A, FCGR2A, FCGR3B
15Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome. (15748958)Geleijns K.... Jacobs B.C.2005FAS
16T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. (16170091)Csurhes P.A.... McCombe P.A.2005MBP, IFNG, PMP22
17Serum tumour necrosis factor-alpha and soluble tumour necrosis factor receptors levels in patients with Guillain-Barre syndrome. (14653854)Radhakrishnan V.V.... Nair M.D.2004TNF, TNFRSF1B
18Immunoglobulin KM genes in Guillain-Barre syndrome. (12736802)Pandey J.P.... Vedeler C.A.2003IGKC
19Circulating tumour necrosis factor alpha & soluble TNF receptors in patients with Guillain-Barre syndrome. (14609050)Radhakrishnan V.V.... Nair M.D.2003TNF, TNFRSF1B, TNFRSF1A
20Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. (12959218)Press R.... Link H.2003CCL21, CXCL12, CCL19
21Interleukin-10 promoter polymorphisms in patients with Guillain-Barre syndrome. (12799024)Myhr K.M.... Vedeler C.A.2003IL10
22Detection of galE gene by polymerase chain reaction in campylobacters associated with Guillain-Barre syndrome. (14602483)Nawaz M.S.... Khan A.A.2003GALE
23Intravenous immunoglobulin reduces serum tumor necros is factor alpha in patients with Guillain-Barre syndrome. (14742928)Reuben S.... Radhakrishnan V.V.2003TNF
24Apolipoprotein E genotypes and clinical outcome in Guillain-Barre syndrome. (12810796)Pritchard J.... Nicoll J.A.2003APOE
25Cutaneous innervation in Guillain-Barre syndrome: pathology and clinical correlations. (12538405)Pan C.L.... Hsieh S.T.2003PGPEP1
26IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barre syndrome. (10762510)van der Pol W.L.... Van de Winkel J.G.2000FCRL6
27HLA alleles in patients with Guillain-Barre syndrome. (11776098)Li H.... Wang S.2000HLA-DQA1, HLA-DQB1, HLA-DRB1
28Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barre syndrome after Campylobacter jejuni enteritis. (10337924)Koga M.... Hirata K.1999CD79A
29T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barre syndrome. (9455979)Dahle C.... Ernerudh J.1997PMP2
30Differential distribution of HLA alleles in two forms of Guillain-Barre syndrome. (9396707)Monos D.S.... McKhann G.M.1997HLA-DRB4
31Antibody responses to P0 and P2 myelin proteins in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. (7689591)Khalili-Shirazi A.... Hughes R.A.1993PMP2
32T cell responses to myelin proteins in Guillain-Barre syndrome. (1279128)Khalili-Shirazi A.... Gregson N.1992MPZ

Expression for genes affiliated with Guillain-barre Syndrome

Sources:
1BioGPS
See all sources
Expression patterns in normal tissues for genes affiliated with Guillain-barre Syndrome

Pathways for genes affiliated with Guillain-barre Syndrome

Sources:
20KEGG, 41Thomson Reuters, 37R&D Systems, 10EMD Millipore, 38Reactome, 36QIAGEN
See all sources

Pathways related to guillain-barre syndrome according to GeneDecks:

(show top 50)    (show all 67)
idPathwayScoreTop Affiliating Genes
1Cell adhesion molecules (CAMs)2010.7MPZ
2Immune response_NFAT in immune response4110.7HLA-DRB4
3IL-15 Signaling and its Primary Biological Effects in Different Immune Cell Types3710.6TNFRSF1A
4Graft-versus-host disease2010.5HLA-DQA1, HLA-DRB4
5Immune response Antigen presentation by MHC class II1010.4HLA-DRB4, HLA-DQA1
6Amoebiasis209.9NOS2, CD1D
7Antigen processing and presentation209.8HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1
8MHC class II antigen presentation389.8HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1
9Immune response NFAT in immune response109.7HLA-DRB4, HLA-DQB1, HLA-DQA1, IGKC, CD79A
10CTL Mediated Apoptosis369.7HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1
11Immune response_Antigen presentation by MHC class II419.7HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1
12Viral myocarditis209.7HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1, CD40LG
1314-3-3 and Regulation of BAD Activity369.5TNFRSF1B, TNFRSF1A, TNF, YWHAQ
14Apoptosis and survival_Anti-apoptotic TNFs/NF-kB/Bcl-2 pathway419.4TNFRSF1B, TNFRSF1A, TNF, CD40LG
15Apoptosis and survival Anti-apoptotic TNFs/NF-kB/Bcl-2 pathway109.4TNFRSF1B, TNFRSF1A, TNF, CD40LG
16Apoptotic Pathways Triggered By HIV1369.4TNFRSF1B, TNFRSF1A, TNF, CCR5
17Tec Kinases Signaling369.4CXCL12, TNFRSF1B, CCL19, CCL21, CCR5, IL10
18Calcium Mediated T-Cell Apoptosis369.3HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1
19Apoptosis and survival_Apoptotic TNF-family pathways419.3TNFRSF1B, TNFRSF1A, TNF, FAS
20Apoptosis and survival Apoptotic TNF-family pathways109.3TNFRSF1B, TNFRSF1A, TNF, FAS
21Cellular Transformation by HTLV1369.2SRF, TNFRSF1B, TNFRSF1A, TNF, IFNG
22G-protein signaling N-RAS regulation pathway109.1HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1
23Phagosome209.0TUBB, HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1, MBL2
24Hematopoietic cell lineage209.0CR1, TNF, HLA-DRB4, HLA-DRB1, CD1C, CD1D
25Intestinal immune network for IgA production208.8CXCL12, HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1, IL10
26Osteoclast differentiation208.8TNFRSF1A, TNF, IFNG, FCGR3B, FCGR3A, FCGR2A
27IL-2 Signaling and its Primary Biological Effects in Different Immune Cell Types378.8TNFRSF1B, TNFRSF1A, TNF, FAS, IL10
28Autoimmune thyroid disease208.8HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1, FAS, IL10
29NFAT in Immune Response368.8CXCL12, HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1, FCGR3B
30Malaria208.8CD40LG, IL10, IFNG, TNF, CR1
31PEDF Induced Signaling368.7CXCL12, SRF, TNF, CCL19, CCL21, IL10
32African trypanosomiasis208.6TNF, IFNG, FAS, IL10
33Akt Signaling368.6CXCL12, TNFRSF1A, TNF, CCL21, CCR5, IL10
34Staphylococcus aureus infection208.5HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1, MBL2, IL10
35STAT3 Pathway368.4CXCL12, TNFRSF1B, TNFRSF1A, TNF, CCL19, CCL21
36Type I diabetes mellitus208.3TNF, HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1, IFNG
37Asthma208.3TNF, HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1, IL10
38Rheumatoid arthritis208.3CXCL12, TNF, HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1
39Antioxidant Action of Vitamin-C368.1CXCL12, TNFRSF1B, TNFRSF1A, TNF, CCL19, CCL21
40MAPK Family Pathway368.1IL10, CCL21, CCL19, TNF, TNFRSF1A, TNFRSF1B
41Influenza A208.0TNFRSF1A, TNF, HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1
42p38 Signaling368.0CXCL12, TNFRSF1B, TNFRSF1A, TNF, CCL19, CCL21
43Chagas disease (American trypanosomiasis)207.9NOS2, TNFRSF1A, TNF, IFNG, FAS, IL10
44THC Differentiation Pathway367.7TNFRSF1B, IL10, IFNG, HLA-DQA1, HLA-DQB1, HLA-DRB1
45Cytokine-cytokine receptor interaction207.6CXCL12, TNFRSF1B, TNFRSF1A, TNF, IFNG, CCL19
46Allograft rejection207.6IL10, FAS, IFNG, HLA-DQA1, HLA-DQB1, HLA-DRB1
47Systemic lupus erythematosus207.4TNF, HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1, IFNG
48Toxoplasmosis207.0NOS2, TNFRSF1A, TNF, HLA-DRB4, HLA-DRB1, HLA-DQB1
49Leishmaniasis206.9FCGR3A, FCGR3B, IL10, IFNG, HLA-DQA1, HLA-DQB1
50Tuberculosis206.6FCGR2A, NOS2, FCGR3A, FCGR3B, IL10, IFNG

Compounds for genes affiliated with Guillain-barre Syndrome

Sources:
32Novoseek , 42Tocris Bioscience, 9DrugBank, 34PharmGKB, 18HMDB
See all sources

Compounds related to guillain-barre syndrome according to GeneDecks:

(show top 50)    (show all 207)
idCompoundScoreTop Affiliating Genes
1ivig32 10.5FCGR3A, MBP, CCR5
2endotoxin32 10.1TNFRSF1B, TNFRSF1A, CR1, HP, SRF
3pge232 10.1CCL19, TNFRSF1B, ACP1, HP, CCL21
4polyethylene glycol32 9.8GFAP, HP, APOE, MBP
5gaba32 42 10.6MBP, HCRT, TUBB, PMP22, TH, GFAP
6blys32 9.5CD79A, CD40LG, TNFRSF1A
7glatiramer acetate32 9 9 11.2MOG, HLA-DRB1, IFNG, MBP, IL10, PLP1
8rituximab32 34 9 9 12.0CD40LG, CXCL12, FCGR2A, FCGR3A, FCGR3B, CD79A
9n acetylcysteine32 9.0CD79A, MMP9, PLP1, APOE, MBP
10tuberculin32 8.9CD40LG, CD79A, IL10, MBL2, IFNG, HP
11heparin32 9 18 9 11.9CD79A, APOE, MBP, CR1, HP, CXCL12
12estrogen32 8.7GFAP, TH, HCRT, ACP1, NOS2, TUBB
13polysaccharide32 8.7FAS, CCR5, FCGR3B, HP, FCGR2A, CD79A
14h2o232 8.6TUBB, HP, MBP, APOE, FCGR3B, FCGR2A
15calcium32 9 18 9 11.5TNFRSF1A, FCGR2A, INPP5J, MOG, FCGR3A, FCGR3B
16ribavirin32 34 9 9 11.4HP, IFNG, CCR5, MBL2, CD40LG, IL10
17natalizumab32 9 9 10.4TNF, IFNG, FCGR3B, FCGR2A, FCGR3A, IL10
18rantes32 8.4CCL19, CXCL12, TNFRSF1B, TNFRSF1A, IFNG, CCL21
19alanine32 8.3TNFRSF1A, HLA-DRB1, CCR5, MBP, MMP9, CD40LG
20creatinine32 8.3GFAP, FAS, MMP9, CD40LG, MPZ, MBL2
21acetylcholine32 9 18 9 11.3MOG, APOE, CD40LG, MBP, SRF, NOS2
22epinephrine32 9 18 9 11.3MMP9, ACP1, CXCL12, HP, MBP, FAS
23oxygen32 18 9.3TH, GFAP, ACP1, NOS2, CR1, MBL2
24cholesterol32 9 18 9 11.3APOE, GFAP, HCRT, SRF, TNFRSF1B, TNFRSF1A
25glutamate32 8.2ACP1, CXCL12, TH, GFAP, HCRT, MPZ
26etanercept32 9 9 10.2FCGR2A, FCGR3B, IFNG, FCGR3A, IL10, TNFRSF1B
27glutamine32 8.2TH, CRYAB, TUBB, HLA-DQB1, CCR5, ACP1
28adalimumab32 9 9 10.1FCGR3A, FCGR3B, TNF, IFNG, IL10, CD79A
29cysteine32 8.1IFNG, CCR5, PMP22, TNFRSF1B, TH, TUBB
30tarc32 8.1IL10, CCR5, CCL21, CCL19, TNF, CXCL12
31aspartate32 8.0CD40LG, MPZ, MMP9, APOE, MBL2, PMP22
32vegf32 8.0CXCL12, TH, GFAP, ACP1, SRF, APOE
33arginine32 8.0PMP22, GFAP, ACP1, PLP1, SRF, TNFRSF1B
34okt332 8.0CD40LG, IL10, CD79A, FAS, IFNG, TNFRSF1A
35adenylate32 7.9HCRT, CR1, MBP, MMP9, CD40LG, TUBB
36neopterin32 7.8CD40LG, HP, SRF, TNFRSF1A, TNF, CD79A
37ccl332 7.8IFNG, CXCL12, CCL19, TNF, CCL21, CCR5
38prednisolone32 9 9 9.6CD79A, CR1, TNF, IFNG, MBP, MBL2
39methotrexate32 34 42 9 9 11.4MBP, HLA-DRB1, SRF, TNFRSF1B, TNFRSF1A, CD79A
40herbimycin a32 42 8.2TNFRSF1A, NOS2, ACP1, CXCL12, MMP9, IFNG
41lipid32 6.9GFAP, APOE, FCGR3B, FCGR2A, INPP5J, CD1C
42indomethacin32 9 9 8.8MBP, APOE, TNF, CD79A, CD40LG, NOS2
43paraffin32 6.8TUBB, HMGA2, MBP, MBL2, FAS, APOE
44retinoic acid32 42 18 8.4TNFRSF1B, SRF, CR1, PLP1, ACP1, GFAP
45tyrosine32 6.4HLA-DQB1, TNFRSF1B, SRF, CR1, MBP, ACP1
46serine32 6.2MPZ, TNFRSF1B, TNFRSF1A, TUBB, HP, CCR5
47cyclosporin a32 42 7.2HP, IFNG, MBP, FAS, APOE, IL10
48actinomycin d32 6.0TNFRSF1A, TNF, HMGA2, HP, IFNG, CCR5
49cycloheximide32 5.9CXCL12, GFAP, NOS2, CR1, SRF, MMP9
50dexamethasone32 42 34 9 9 9.3ACP1, CXCL12, TH, GFAP, HCRT, SRF

GO Terms for genes affiliated with Guillain-barre Syndrome

Sources:
12Gene Ontology
See all sources

Cellular components related to guillain-barre syndrome according to GeneDecks:

(show all 16)
idNameGO IDScoreTop Affiliating Genes
1compact myelinGO:04321810.5PMP22, PLP1, MBP
2MHC class II protein complexGO:0426139.7HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1
3clathrin-coated endocytic vesicle membraneGO:0306699.6HLA-DQA1, HLA-DQB1, HLA-DRB1, HLA-DRB4
4integral to lumenal side of endoplasmic reticulum membraneGO:0715569.6HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1
5trans-Golgi network membraneGO:0325889.6HLA-DQA1, HLA-DQB1, HLA-DRB1, HLA-DRB4
6endosome membraneGO:0100089.5CD1A, CD1D, CD1C, HLA-DQA1, HLA-DQB1
7transport vesicle membraneGO:0306589.5HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1
8ER to Golgi transport vesicle membraneGO:0125079.5HLA-DQA1, HLA-DQB1, HLA-DRB1, HLA-DRB4
9endocytic vesicle membraneGO:0306669.4HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1
10lysosomal membraneGO:0057659.0HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1, CD1D
11membrane raftGO:0451218.6CD79A, FAS, TNF, TNFRSF1A, TNFRSF1B
12integral to plasma membraneGO:0058878.1CR1, TNFRSF1A, TNF, HLA-DRB4, HLA-DRB1, HLA-DQA1
13external side of plasma membraneGO:0098977.6CD79A, CXCL12, TNF, HLA-DRB4, HLA-DRB1, IFNG
14extracellular regionGO:0055767.1CXCL12, HCRT, TNFRSF1B, TNFRSF1A, HP, IFNG
15extracellular spaceGO:0056156.6IFNG, HP, TNF, TNFRSF1A, CXCL12, CCL19
16plasma membraneGO:0058865.9HLA-DRB1, HLA-DQB1, HLA-DQA1, IGKC, HLA-DRB4, TNF

Biological processes related to guillain-barre syndrome according to GeneDecks:

(show all 29)
idNameGO IDScoreTop Affiliating Genes
1dendritic cell chemotaxisGO:00240710.3CCR5, CCL21, CCL19
2negative regulation of leukocyte apoptotic processGO:200010710.2CXCL12, CCL19, CCL21
3negative regulation of neuron projection developmentGO:01097710.2PMP22, GFAP, INPP5J
4detection of bacteriumGO:01604510.1HLA-DRB4, HLA-DRB1, CD1D
5antigen processing and presentationGO:01988210.0CD1E, CD1A, CD1C, IFNG
6positive regulation of interleukin-12 productionGO:03273510.0CD40LG, CCL19, IFNG
7immunoglobulin production involved in immunoglobulin mediated immune responseGO:00238110.0HLA-DRB4, HLA-DRB1, HLA-DQB1
8humoral immune response mediated by circulating immunoglobulinGO:00245510.0HLA-DQB1, HLA-DRB1, HLA-DRB4
9B cell proliferationGO:0421009.7CD79A, CD40LG, IL10
10positive regulation of MHC class II biosynthetic processGO:0453489.7IFNG, IL10, CD40LG
11T cell costimulationGO:0312959.5HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1, CCL19, CCL21
12negative regulation of interferon-gamma productionGO:0326899.5HLA-DRB4, HLA-DRB1, IL10
13positive regulation of killing of cells of other organismGO:0517129.4NOS2, IFNG
14positive regulation of vitamin D biosynthetic processGO:0605579.4TNF, IFNG
15negative regulation of T cell proliferationGO:0421309.3IL10, HLA-DRB1, HLA-DRB4
16interferon-gamma-mediated signaling pathwayGO:0603339.3HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1, IFNG
17positive regulation of calcidiol 1-monooxygenase activityGO:0605599.2TNF, IFNG
18cellular response to lipopolysaccharideGO:0712229.1IL10, CCR5, IFNG, TNFRSF1B, NOS2
19positive regulation of membrane protein ectodomain proteolysisGO:0510449.1TNFRSF1B, TNF, IFNG, APOE
20negative regulation of interleukin-6 productionGO:0327159.1TNFRSF1A, TNF, IL10
21cytokine-mediated signaling pathwayGO:0192219.0TNFRSF1A, HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1, IFNG
22negative regulation of gene expressionGO:0106298.9TNF, TNFRSF1A, CRYAB, NOS2
23negative regulation of growth of symbiont in hostGO:0441308.8TNF, IFNG, MBL2, IL10
24receptor biosynthetic processGO:0328008.7TNF, IL10
25response to virusGO:0096158.6CXCL12, TNF, HMGA2, IFNG, CCL19
26inflammatory responseGO:0069548.6TNFRSF1B, TNFRSF1A, TNF, CCL19, CCL21, CCR5
27immune responseGO:0069558.3CD1E, CXCL12, HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DQA1
28anti-apoptosisGO:0069168.3CRYAB, TNF, FAS, APOE, IL10, CD40LG
29response to hypoxiaGO:0016667.7CXCL12, TH, NOS2, CRYAB, SRF, TNFRSF1A

Molecular functions related to guillain-barre syndrome according to GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1CCR7 chemokine receptor bindingGO:03173210.2CCL21, CCL19
2IgG bindingGO:01986410.0FCGR2A, FCGR3A, FCGR3B
3exogenous lipid antigen bindingGO:0308849.9CD1D, CD1C
4tumor necrosis factor-activated receptor activityGO:0050319.8TNFRSF1B, TNFRSF1A, FAS
5MHC class II receptor activityGO:0323959.5HLA-DQA1, HLA-DQB1, HLA-DRB1, HLA-DRB4

Sources for Guillain-barre Syndrome

2CDC
11FMA
18HMDB
19ICD9CM
20KEGG
24MeSH
25MGI
27NCIt
28NDF-RT
31NINDS
32Novoseek
33OMIM
35PubMed
36QIAGEN
43UMLS